Chemically modified peptides targeting the PDZ domain of GIPC as a therapeutic approach for cancer. - Wikidata - wikimedia - TriplyDB

Chemically modified peptides targeting the PDZ domain of GIPC as a therapeutic approach for cancer.

Chemically modified peptides targeting the PDZ domain of GIPC as a therapeutic approach for cancer.

http://www.wikidata.org/entity/Q35903324

about

KIF14 negatively regulates Rap1a-Radil signaling during breast cancer progression Inhibition of N-Methyl-D-aspartate-induced Retinal Neuronal Death by Polyarginine Peptides Is Linked to the Attenuation of Stress-induced Hyperpolarization of the Inner Mitochondrial Membrane Potential Discovery and confirmation of ligand binding specificities of the Schistosoma japonicum polarity protein Scribble Functional proteomics, human genetics and cancer biology of GIPC family members Chemically modified peptide scaffolds target the CFTR-associated ligand PDZ domain Thiomyristoyl peptides as cell-permeable Sirt6 inhibitors.Molecular characterization and ligand binding specificity of the PDZ domain-containing protein GIPC3 from Schistosoma japonicum.Network analysis of circular permutations in multidomain proteins reveals functional linkages for uncharacterized proteins.From antimicrobial to anticancer peptides. A review.Ligand binding by PDZ domains.On the binding affinity of macromolecular interactions: daring to ask why proteins interact.Inhibition of endoglin-GIPC interaction inhibits pancreatic cancer cell growth.Impact of the adaptor protein GIPC1/Synectin on radioresistance and survival after irradiation of prostate cancer.TrkB-enhancer facilitates functional recovery after traumatic brain injury.Chemically-Modified Peptides Targeting the PDZ Domain of GIPC as a Therapeutic Approach for Cancer.

P2860

Q24305208-28497EFC-99D8-4406-80B4-4715FF271BB1 Q28388814-08626AE0-37B1-458A-92C8-A43C4D813325 Q28538306-D7E7BF64-4128-494C-9611-BBD7FC532924 Q30452637-9606105E-9569-469F-9A34-18C1104A09EF Q34066239-99C55E93-F8F7-43CE-B7F7-449884886C5E Q34167531-C5523D3E-8E24-440E-AE21-251C6E3FE28D Q34439128-47FF49DA-EF1B-41BB-B336-5995FFD7FDD5 Q35115360-5F6556EB-B43D-4B0E-8BB8-5A309D7C9C3C Q37207728-464708C3-9699-4684-9E9B-5FCEB48826A1 Q38016834-B11A523B-555B-4272-8C70-458A77F486CD Q38067023-4011FD13-BEF4-4CB6-B51D-153F756DF245 Q38965801-D9E9B2C4-9AB3-4DEC-BDB1-13AE2D86CFB7 Q39249070-DDBB911E-273A-489F-B22B-66566E01F7B3 Q41480262-E68C310A-A327-40A7-9DEC-9D517FFFFD85 Q41844563-DCD3268C-4491-4951-8769-203AFA1F4C9A

P2860

Chemically modified peptides targeting the PDZ domain of GIPC as a therapeutic approach for cancer.

http://www.wikidata.org/entity/Q35903324

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Chemically modified peptides t ...... erapeutic approach for cancer.

@ast

Chemically modified peptides t ...... erapeutic approach for cancer.

@en

type

label

Chemically modified peptides t ...... erapeutic approach for cancer.

@ast

Chemically modified peptides t ...... erapeutic approach for cancer.

@en

prefLabel

Chemically modified peptides t ...... erapeutic approach for cancer.

@ast

Chemically modified peptides t ...... erapeutic approach for cancer.

@en

P1433

Q35903324-66665EF0-2A35-4AB6-8175-1EF262EA9F02

P1476

Q35903324-C0667897-CF98-49E5-B4F1-254A4B904207

P2093

Q35903324-54CA641C-CA03-49E4-BDC6-A0A7002E5592

Q35903324-786969BB-E190-4F3A-955A-CB90898CC853

Q35903324-9312B700-6112-4FAB-A4CC-306E0498DCBB

Q35903324-A43C57EB-7E21-4F4F-9E39-101E2A48D893

Q35903324-A6C80C04-7904-4942-A0D6-D979D2AFF91A

Q35903324-CCABE4AF-2E61-426F-ACA3-4117CD5D1A3B

Q35903324-FEE4677A-57EC-4A70-9935-A3DFF33BA031

P2860

Q35903324-03A567F0-7D5A-4418-8E81-6680D58E7AC3

Q35903324-075BCCB9-35FE-4435-A020-88A201EAB449

Q35903324-08C90996-E8AB-4D7B-92DE-4D02BA746352

Q35903324-1081B753-BDC7-4415-B8B3-DF84AA536071

Q35903324-148F299A-EFFC-48B6-80C1-6A743140D2CF

Q35903324-15E39C2B-1733-40B6-B439-3542E3182DCA

Q35903324-179E5796-2200-4439-B354-E119E31DE512

Q35903324-1C80E368-B533-47EE-9EBA-61E039D35DE4

Q35903324-1D54314D-0876-4ED8-925B-90FF7ED600BB

Q35903324-1E2C1208-E3FD-4012-8F33-278F370F84D1

P304

Q35903324-E6658F8A-8C54-4D84-9D14-F2429478BF7B

P31

Q35903324-C9D673DA-8BAC-4EE1-8EA1-8C65A2B53E5B

P356

Q35903324-87D47EF5-C037-401E-8ADB-C10D30889E55

P433

Q35903324-7C071ABF-4393-42C3-96C2-FBF4560D5BF0

P478

Q35903324-597694A9-7EA3-4F06-AA7F-9B3C2B2EE300

P577

Q35903324-BA43AFE8-57C7-41B3-925F-9DAEE2DDDBE4

P5875

Q35903324-F2D06BDC-3C2A-47EF-90D9-9BE2C24C5DA4

P698

Q35903324-351D80A0-4FDE-4DEF-A187-4CD7C8E64DE8

P932

Q35903324-7CCAA6D9-E322-43FA-A460-00A7A6B29AC3

P356

P1433

ACS Chemical Biology

P1476

Chemically modified peptides t ...... erapeutic approach for cancer.

@en

P2093

Chamila N Rupasinghe

http://www.w3.org/2001/XMLSchema#string

Chitta Ranjan Patra

http://www.w3.org/2001/XMLSchema#string

Debabrata Mukhopadhyay

http://www.w3.org/2001/XMLSchema#string

Enfeng Wang

http://www.w3.org/2001/XMLSchema#string

Mark R Spaller

http://www.w3.org/2001/XMLSchema#string

Santanu Bhattacharya

http://www.w3.org/2001/XMLSchema#string

Shamit K Dutta

http://www.w3.org/2001/XMLSchema#string

P2860

GIPC, a PDZ domain containing protein, interacts specifically with the C terminus of RGS-GAIP

A thermodynamic ligand binding study of the third PDZ domain (PDZ3) from the mammalian neuronal protein PSD-95

Expression of human GIPC1 in normal tissues, cancer cell lines, and primary tumors

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

Membrane interaction of small N-myristoylated peptides: implications for membrane anchoring and protein-protein association.

Structure and position of the N-terminal membrane-binding domain of pp60src at the membrane interface.

Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation.

Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.

Molecular models of protein kinase 6 from Plasmodium falciparum.

A chemical library approach to organic-modified peptide ligands for PDZ domain proteins: a synthetic, thermodynamic and structural investigation.

P304

770-779

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/CB200536R

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221793879

http://www.w3.org/2001/XMLSchema#string

P698

22292614

http://www.w3.org/2001/XMLSchema#string

P932

3331932

http://www.w3.org/2001/XMLSchema#string